Scientist – analytical chemistry in early drug development
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Ballerup
Do you want an important role in developing treatments of skin diseases?
This is your chance to join one of the world’s leading companies within dermatology and to set your mark on the quality of life for millions of patients around the world. Global Research and Development in LEO Pharma devotes its efforts to develop innovative drugs for the treatment of skin diseases like psoriasis and eczema. In the early development phases, vital parts of succeeding is founded in 1) Understanding how the chemical properties of our compounds will impact the drug developability, i.e. pre-formulation analysis, and 2) Developing analytical methods to determine the assay and impurity profile for drug substance and drug product. We have an ambition to excel in this and that is why we need your scientific thinking!
Analytical chemistry and early phase projects with small molecules
You will immediately take an active, operational part in driving early research & development projects forward. Here you will get to use your scientific knowledge and analytical mindset.
In detail you will be expected to:
Be an integral part of our project teams from lead optimization to phase 2 clinical trials, where you will bring your analytical knowledge into play in a project specific manner Develop and validate analytical methods (mainly HPLC) and conduct stability studies and pre-formulation studies by planning and reporting laboratory experiments together with our skilled technicians in a non-GMP environment. Occasionally preparing and conducting experiment in the analytical laboratory Occasionally you will handle GMP release of drug substance and drug product Write analytical documents for the health authorities relating to early phase clinical trials, such as IMPDs, and collaborate with CMOs in method validation and analysis of IMP productions Participate in cross-functional teams to continuously improve our ways of working across the organisation, e.g. within compliance and quality related issues.
Passionate profile with drive and ambitions
We are looking for a highly motivated and ambitious scientist with an outgoing spirit. It is an advantage if you have a proven track record of analytical project work in the research and development phases in the pharmaceutical industry, and it is a further advantage if you have experience in compliance and quality. You hold a MSc and preferably a PhD in pharmaceutical sciences or related disciplines.
To help succeed in our ambition of excelling in early phase analytical work, you have a logical and analytical way of thinking, you are ready to challenge status quo, and you have a desire to communicate and collaborate across disciplines.
In our R&D environment it is important that you are curious and have a decisive, flexible and proactive mindset.
Early Formulation and Analytics
You will join 18 colleagues in the department Early Formulation and Analytics. Our focus is to impact and support the early oral and topical R&D projects within small molecules in LEO Pharma. The atmosphere is open and informal with enthusiastic and dedicated people. We are driven by courage, trust and mutual respect and helpfulness – and not to forget having a good time together.
You are looking for work experience with opportunities for personal development and a place where your professional competences will be used. We are looking forward getting you on board joining our efforts towards helping people achieve healthy skin.
This is your chance to join one of the world’s leading companies within dermatology and to set your mark on the quality of life for millions of patients around the world. Global Research and Development in LEO Pharma devotes its efforts to develop innovative drugs for the treatment of skin diseases like psoriasis and eczema. In the early development phases, vital parts of succeeding is founded in 1) Understanding how the chemical properties of our compounds will impact the drug developability, i.e. pre-formulation analysis, and 2) Developing analytical methods to determine the assay and impurity profile for drug substance and drug product. We have an ambition to excel in this and that is why we need your scientific thinking!
Analytical chemistry and early phase projects with small molecules
You will immediately take an active, operational part in driving early research & development projects forward. Here you will get to use your scientific knowledge and analytical mindset.
In detail you will be expected to:
Passionate profile with drive and ambitions
We are looking for a highly motivated and ambitious scientist with an outgoing spirit. It is an advantage if you have a proven track record of analytical project work in the research and development phases in the pharmaceutical industry, and it is a further advantage if you have experience in compliance and quality. You hold a MSc and preferably a PhD in pharmaceutical sciences or related disciplines.
To help succeed in our ambition of excelling in early phase analytical work, you have a logical and analytical way of thinking, you are ready to challenge status quo, and you have a desire to communicate and collaborate across disciplines.
In our R&D environment it is important that you are curious and have a decisive, flexible and proactive mindset.
Early Formulation and Analytics
You will join 18 colleagues in the department Early Formulation and Analytics. Our focus is to impact and support the early oral and topical R&D projects within small molecules in LEO Pharma. The atmosphere is open and informal with enthusiastic and dedicated people. We are driven by courage, trust and mutual respect and helpfulness – and not to forget having a good time together.
You are looking for work experience with opportunities for personal development and a place where your professional competences will be used. We are looking forward getting you on board joining our efforts towards helping people achieve healthy skin.
Information og data
Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Ballerup.
Jobbet er oprettet på vores service den 15.7.2019, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forsker
- Ballerup
- Søndag den 18. august 2019
Lignende jobs
-
Adjunkt/lektor med stærk kvantitativ forskningspro...
Kan du udvikle, designe og gennemføre kvantitative undersøgelser? Har du erfaring med forskningsansøgninger, og kan du undervise og inspirere en ny generation af socialrådgivere? Så har vi stilling..- Forsker
- København V
-
Adjunkt/lektor med juridisk profil til Institut fo...
Er du uddannet jurist eller cand.soc.jur. med praksiserfaring fra det sociale område, og har du lyst til at uddanne fremtidens socialrådgivere og bidrage til vidensgrundlaget på området? Så er du m..- Forsker
- København V
-
Studentermedhjælper til projektadministrativ under...
Er du studerende, og har du lyst til at bidrage til den administrative understøttelse af forskningsprojekter på en af landet største læreruddannelser? Så er det måske dig, vi søger som vores nye st..- Forsker
- København V
-
Postdoc in application of machine and deep learnin...
- Forsker
- København
Statistik over udbudte jobs som forskere i Ballerup
Herunder ser du udviklingen i udbudte forsker i Ballerup over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.
Se flere statistikker her:
Statistik over udbudte forskere i Ballerup over tid
Dato | Alle jobs som forskere |
---|---|
9. november 2024 | 2 |
8. november 2024 | 1 |
29. oktober 2024 | 1 |
28. oktober 2024 | 1 |
27. oktober 2024 | 1 |
26. oktober 2024 | 1 |
25. oktober 2024 | 1 |
24. oktober 2024 | 1 |
16. oktober 2024 | 1 |
15. oktober 2024 | 1 |
14. oktober 2024 | 1 |
13. oktober 2024 | 1 |
12. oktober 2024 | 1 |
11. oktober 2024 | 1 |
10. oktober 2024 | 1 |